Characterization of bone marrow stromal abnormalities in a patient with constitutional trisomy 8 mosaicism and myelodysplastic syndrome

被引:31
作者
Narendran, A
Hawkins, LM
Ganjavi, H
Vanek, W
Gee, MFW
Barlow, JW
Johnson, G
Malkin, D
Freedman, MH
机构
[1] Alberta Childrens Prov Gen Hosp, So Alberta Childrens Canc Program, Calgary, AB T2T 5C7, Canada
[2] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
关键词
bone marrow stroma; cytokines; leukemia; myelodysplastic syndrome;
D O I
10.1080/08880010490276917
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The development of myeloid leukemias and myelodysplastic syndrome (MDS) is common in children with trisomy 8 mosaicism. However, the mechanisms by which the presence of an additional chromosome 8 translates to an increased risk of leukemias and MDS is currently unknown. The authors describe the analysis of stromal cells from a pediatric MDS patient with constitutional trisomy 8. Patient and control marrow stromal cells were analyzed for alterations in cytokine production. Clonogenic assays were used to examine stromal support for hematopoiesis. The interplay between leukemia cells and stroma was studied by co-culture experiments. The results indicate that stromal cell function in this patient was seriously altered in favor of progenitor cell proliferation and expansion. This indicates that constitutional trisomy 8 in stromal cells plays a critical role in the pathogenesis of MDS.
引用
收藏
页码:209 / 221
页数:13
相关论文
共 31 条
[1]   Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes [J].
Aguayo, A ;
Kantarjian, HM ;
Estey, EH ;
Giles, FJ ;
Verstovsek, S ;
Manshouri, T ;
Gidel, C ;
O'Brien, S ;
Keating, MJ ;
Albitar, M .
CANCER, 2002, 95 (09) :1923-1930
[2]   Establishment of stromal cell line from an MDS RA patient which induced an apoptopic change in hematopoietic and leukemic cells in vitro [J].
Aizawa, S ;
Hiramoto, M ;
Hoshi, H ;
Toyama, K ;
Shima, D ;
Handa, H .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (02) :148-155
[3]   Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes [J].
Alvi, S ;
Shaher, A ;
Shetty, V ;
Henderson, B ;
Dangerfield, B ;
Zorat, F ;
Joshi, L ;
Anthwal, S ;
Lisak, L ;
Little, L ;
Gezer, S ;
Mundle, S ;
Reddy, PL ;
Allampallam, K ;
Huang, XK ;
Galili, N ;
Borok, RZ ;
Raza, A .
LEUKEMIA RESEARCH, 2001, 25 (11) :941-954
[4]   Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes [J].
Bellamy, WT ;
Richter, L ;
Sirjani, D ;
Roxas, C ;
Glinsmann-Gibson, B ;
Frutiger, Y ;
Grogan, TM ;
List, AF .
BLOOD, 2001, 97 (05) :1427-1434
[5]   SERUM STEM-CELL FACTOR CONCENTRATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES [J].
BOWEN, D ;
YANCIK, S ;
BENNETT, L ;
CULLIGAN, D ;
RESSER, K .
BRITISH JOURNAL OF HAEMATOLOGY, 1993, 85 (01) :63-66
[6]  
Broxmeyer HE, 1995, INT J HEMATOL, V62, P203
[7]   GROWTH-FACTOR MODULATION OF P53-MEDIATED GROWTH ARREST VERSUS APOPTOSIS [J].
CANMAN, CE ;
GILMER, TM ;
COUTTS, SB ;
KASTAN, MB .
GENES & DEVELOPMENT, 1995, 9 (05) :600-611
[8]   Low plasma stem cell factor levels correlate with in vitro leukemic growth in myelodysplastic syndromes [J].
Cortelezzi, A ;
Cattaneo, C ;
Cristiani, S ;
Sarina, B ;
Pomati, M ;
Silvestris, I ;
Ibatici, A ;
Maiolo, AT .
LEUKEMIA RESEARCH, 1999, 23 (03) :271-275
[9]   FUNCTIONAL-STUDIES OF BONE-MARROW HEMATOPOIETIC AND STROMAL CELLS IN THE MYELODYSPLASTIC SYNDROME (MDS) [J].
COUTINHO, LH ;
GEARY, CG ;
CHANG, J ;
HARRISON, C ;
TESTA, NG .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (01) :16-25
[10]  
ELIAS JA, 1994, AM J PHYSIOL, V266, P426